EcoR1 Capital as of March 31, 2025
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 44 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 15.4 | $260M | 12M | 21.87 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 12.6 | $212M | 1.7M | 124.15 | |
| Zymeworks Del (ZYME) | 12.2 | $206M | 17M | 11.91 | |
| Anaptysbio Inc Common (ANAB) | 8.7 | $147M | 7.9M | 18.59 | |
| Crinetics Pharmaceuticals In (CRNX) | 8.5 | $144M | 4.3M | 33.54 | |
| Prothena Corp SHS (PRTA) | 8.5 | $143M | 12M | 12.38 | |
| Sarepta Therapeutics (SRPT) | 4.9 | $83M | 1.3M | 63.82 | |
| Xencor (XNCR) | 3.9 | $65M | 6.1M | 10.64 | |
| Crispr Therapeutics Namen Akt (CRSP) | 2.8 | $47M | 1.4M | 34.03 | |
| Uniqure Nv SHS (QURE) | 2.6 | $44M | 4.1M | 10.60 | |
| Janux Therapeutics (JANX) | 2.4 | $40M | 1.5M | 27.00 | |
| Immunome (IMNM) | 1.6 | $28M | 4.1M | 6.73 | |
| Eton Pharmaceuticals (ETON) | 1.5 | $26M | 2.0M | 12.98 | |
| Madrigal Pharmaceuticals (MDGL) | 1.5 | $25M | 75k | 331.23 | |
| Oric Pharmaceuticals (ORIC) | 1.1 | $19M | 3.4M | 5.58 | |
| Akero Therapeutics (AKRO) | 1.1 | $18M | 440k | 40.48 | |
| Kura Oncology (KURA) | 1.0 | $17M | 2.6M | 6.60 | |
| Tectonic Therapeutic (TECX) | 1.0 | $17M | 935k | 17.71 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $17M | 558k | 29.52 | |
| Neurogene (NGNE) | 0.9 | $15M | 1.3M | 11.71 | |
| Tango Therapeutics (TNGX) | 0.9 | $15M | 11M | 1.37 | |
| Voyager Therapeutics (VYGR) | 0.8 | $13M | 3.9M | 3.38 | |
| Beam Therapeutics (BEAM) | 0.6 | $10M | 527k | 19.53 | |
| Mbx Biosciences (MBX) | 0.6 | $9.3M | 1.3M | 7.38 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.5 | $8.3M | 1.5M | 5.70 | |
| Replimune Group (REPL) | 0.5 | $8.3M | 850k | 9.75 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $7.7M | 910k | 8.49 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $6.8M | 862k | 7.93 | |
| Verve Therapeutics (VERV) | 0.3 | $5.7M | 1.3M | 4.57 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.3 | $5.4M | 27M | 0.20 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $3.9M | 155k | 25.12 | |
| Aadi Bioscience (WHWK) | 0.2 | $3.7M | 2.1M | 1.78 | |
| Atara Biotherapeutics Com New (ATRA) | 0.2 | $3.4M | 573k | 5.94 | |
| Solid Biosciences Com New (SLDB) | 0.2 | $2.8M | 745k | 3.70 | |
| Keros Therapeutics (KROS) | 0.1 | $1.9M | 188k | 10.19 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.1 | $1.7M | 963k | 1.76 | |
| Relay Therapeutics (RLAY) | 0.1 | $1.7M | 641k | 2.62 | |
| Kalaris Therapeutics (KLRS) | 0.1 | $1.6M | 202k | 8.03 | |
| Prime Medicine (PRME) | 0.1 | $1.4M | 700k | 1.99 | |
| Mestera (MTSR) | 0.1 | $1.4M | 50k | 27.22 | |
| Tscan Therapeutics (TCRX) | 0.1 | $915k | 663k | 1.38 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $777k | 67k | 11.66 | |
| Aligos Therapeutics Com New (ALGS) | 0.0 | $731k | 89k | 8.25 | |
| Upstream Bio (UPB) | 0.0 | $367k | 60k | 6.12 |
